SD Biosensor Inc - Asset Resilience Ratio
SD Biosensor Inc (137310) has an Asset Resilience Ratio of 13.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 137310 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how SD Biosensor Inc's Asset Resilience Ratio has changed over time. See SD Biosensor Inc net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down SD Biosensor Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SD Biosensor Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩541.28 Billion | 13.59% |
| Total Liquid Assets | ₩541.28 Billion | 13.59% |
Asset Resilience Insights
- Moderate Liquidity: SD Biosensor Inc has 13.59% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
SD Biosensor Inc Industry Peers by Asset Resilience Ratio
Compare SD Biosensor Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for SD Biosensor Inc (2019–2024)
The table below shows the annual Asset Resilience Ratio data for SD Biosensor Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.47% | ₩290.33 Billion ≈ $196.75 Million |
₩3.89 Trillion ≈ $2.64 Billion |
+5.48pp |
| 2023-12-31 | 1.99% | ₩75.33 Billion ≈ $51.05 Million |
₩3.79 Trillion ≈ $2.57 Billion |
-4.05pp |
| 2022-12-31 | 6.04% | ₩197.03 Billion ≈ $133.52 Million |
₩3.26 Trillion ≈ $2.21 Billion |
-27.70pp |
| 2021-12-31 | 33.74% | ₩1.01 Trillion ≈ $687.11 Million |
₩3.01 Trillion ≈ $2.04 Billion |
+18.61pp |
| 2020-12-31 | 15.13% | ₩221.15 Billion ≈ $149.87 Million |
₩1.46 Trillion ≈ $990.54 Million |
+3.30pp |
| 2019-12-31 | 11.83% | ₩20.08 Billion ≈ $13.60 Million |
₩169.72 Billion ≈ $115.02 Million |
-- |
About SD Biosensor Inc
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volum… Read more